The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWitan Regulatory News (WTAN)

Share Price Information for Witan (WTAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 265.00
Ask: 266.00
Change: -0.50 (-0.19%)
Spread: 1.00 (0.377%)
Open: 267.50
High: 267.50
Low: 265.00
Prev. Close: 265.50
WTAN Live PriceLast checked at -
Witan is an Investment Trust

To achieve an investment total return exceeding that of the benchmark of the Company over the longer term, together with growth in the dividend ahead of inflation through active investment in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Witan Investment Trust

25 Mar 2022 07:00

RNS Number : 9419F
Witan Investment Trust PLC
25 March 2022
 

 

London, UK, 25 March 2022

 

Edison issues review on Witan Investment Trust (WTAN)

Witan Investment Trust (WTAN) has used a multi-manager structure since 2004. However, it has continued to evolve as new opportunities and challenges emerge in investment markets. Performance was good in absolute terms through FY21 but lagged global markets, contributing to lower relative returns over the past five years. WTAN's relative performance is still ahead over 10 years and 2021 saw the 47th consecutive year of dividend increases. The trust's portfolio is well diversified and takes active positions versus stylistic, country and sector comparisons, so we believe there is scope for the recent underperformance to be reversed if the market direction becomes driven by a broader set of sector and geographical factors.

WTAN's current 7.7% share price discount to cum-income NAV is wider than its three, five- and 10-year averages of 5.4%, 4% and 4.8%, respectively. The widened discount is likely due to the recent underperformance, which in our view is backward looking and fails to capture the portfolio's potential for future outperformance.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

David Holder +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEMFDLEESELD
Date   Source Headline
10th Jan 20245:36 pmRNSTransaction in Own Shares
10th Jan 20241:09 pmRNSNet Asset Value(s)
9th Jan 20245:24 pmRNSTransaction in Own Shares
9th Jan 20241:52 pmRNSNet Asset Value(s)
8th Jan 20245:16 pmRNSTransaction in Own Shares
8th Jan 20242:20 pmRNSNet Asset Value(s)
5th Jan 20245:02 pmRNSTransaction in Own Shares
5th Jan 202412:56 pmRNSNet Asset Value(s)
4th Jan 20245:11 pmRNSTransaction in Own Shares
4th Jan 202411:58 amRNSNet Asset Value(s)
3rd Jan 20245:23 pmRNSTransaction in Own Shares
3rd Jan 20241:02 pmRNSNet Asset Value(s)
2nd Jan 20245:15 pmRNSTransaction in Own Shares
2nd Jan 202412:14 pmRNSNet Asset Value(s)
2nd Jan 20249:39 amRNSTotal Voting Rights
29th Dec 20231:00 pmRNSTransaction in Own Shares
29th Dec 202310:41 amRNSNet Asset Value(s)
28th Dec 20235:08 pmRNSTransaction in Own Shares
28th Dec 20231:14 pmRNSNet Asset Value(s)
27th Dec 20235:16 pmRNSTransaction in Own Shares
27th Dec 20232:31 pmRNSNet Asset Value(s)
22nd Dec 20231:02 pmRNSTransaction in Own Shares
22nd Dec 202312:36 pmRNSNet Asset Value(s)
21st Dec 20235:09 pmRNSTransaction in Own Shares
21st Dec 202312:05 pmRNSNet Asset Value(s)
20th Dec 20236:03 pmRNSTransaction in Own Shares
20th Dec 202312:45 pmRNSNet Asset Value(s)
19th Dec 20235:07 pmRNSTransaction in Own Shares
19th Dec 202312:47 pmRNSNet Asset Value(s)
18th Dec 20235:28 pmRNSTransaction in Own Shares
18th Dec 20231:09 pmRNSNet Asset Value(s)
15th Dec 20235:25 pmRNSTransaction in Own Shares
15th Dec 20232:42 pmRNSNet Asset Value(s)
14th Dec 20235:10 pmRNSTransaction in Own Shares
14th Dec 20231:55 pmRNSNet Asset Value(s)
14th Dec 20231:10 pmRNSPortfolio Listing as at 30 November 2023
13th Dec 20235:25 pmRNSTransaction in Own Shares
13th Dec 20231:36 pmRNSMonthly Factsheet as at 30 November 2023
13th Dec 20231:02 pmRNSNet Asset Value(s)
12th Dec 20235:16 pmRNSTransaction in Own Shares
12th Dec 20231:10 pmRNSNet Asset Value(s)
11th Dec 20235:05 pmRNSTransaction in Own Shares
11th Dec 202312:56 pmRNSNet Asset Value(s)
8th Dec 20235:11 pmRNSTransaction in Own Shares
8th Dec 20232:38 pmRNSNet Asset Value(s)
7th Dec 20235:08 pmRNSTransaction in Own Shares
7th Dec 202312:30 pmRNSNet Asset Value(s)
6th Dec 20235:16 pmRNSTransaction in Own Shares
6th Dec 202312:54 pmRNSNet Asset Value(s)
5th Dec 20235:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.